Samsung Biologics reports Q2 2026 financial results
July 23, 2026 | 10:31
Samsung Biologics, listed under ticker 207940.KS, reported financial results for the second quarter of fiscal year 2026, providing an update on its contract development and manufacturing business.
Mobile Version